MedAI Verdict
Billing & coding

AI Medical Billing

Infinitus logo

Infinitus

by Infinitus Systems, Inc.

Last verified

Voice AI agents that call payers to check benefits and prior authorization status for providers and pharma.

At a glance

Pricing
No public price. Contact sales.
HIPAA
Attested
SOC 2
Type II
EHRs
—
Founded
—
On this page

Independent score  ·  By our public rubric

29/100Niche fit

Not rated: too little independent evidence yet.

How it’s computed →
  • Regulatory & Compliance
    10/10

    HIPAA + (SOC2 or BAA) attested

  • Clinical Integration
    0/31.4

    No EHR integrations listed

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    8.4/18

    Mid-tier funding and adoption

  • Sentiment & Transparency
    3.3/6.5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • HIPAA / SOC2 / BAA10/10

    HIPAA + (SOC2 or BAA) attested

Clinical Integration

  • EHR integrations (count)0/18

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal8/12

    Mid-tier funding and adoption

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Pricing transparency3/7

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

Voice AI agents that call payers to check benefits and prior authorization status for providers and pharma.

No public price. Contact sales. HIPAA + SOC 2 Type II attested.

Evidence record

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Infinitus record, https://medaiverdict.com/tools/infinitus-systems, version November 2, 2026

Bottom line

Infinitus Systems, Inc. runs AI agents that phone payers and others to collect benefits and prior authorization status, and its homepage now pitches an "agentic platform" for patient-to-care communication, aimed heavily at pharma. It raised a $51.5M Series C in October 2024. Named customers are payers and drug makers, which makes a pharma support program or payer-facing team the matching profile. Provider billing is one of several uses, which matters to a practice shopping for billing automation specifically.

What do the calling agents do?

The homepage says the agents place calls to gather benefits, prior authorization status and similar data. The vendor describes "patent-pending technology" that enforces verbatim language and controlled responses from pre-approved knowledge bases, with doctors and nurses evaluating performance continuously. The 2024 release calls Infinitus the "first AI platform specifically built to automate manual healthcare phone calls" and says a payor knowledge graph was built from more than 4 million calls.

Current product names are AI agents, Lens, Copilots and Studio. The homepage figures are the vendor's: a "0%" under-triage rate, 4.9 out of 5 professionalism, "3x" faster time to therapy and "up to 5x" ROI. No EHR integration is named.

How much has it raised, and do the totals agree?

Ankit Jain is CEO and Shyam Rajagopalan CTO. The Series B was $30M. The Series C of $51.5M was announced on October 23, 2024 and led by Andreessen Horowitz, with Memorial Hermann, Kleiner Perkins, Coatue and GV. The release gives $102.9M raised in total, while a Crunchbase snippet shows $51.4M to date. The About page links a Bloomberg article that it describes as putting the valuation above $600M.

Which customers does the vendor name?

The 2024 release claimed 44% of the Fortune 50 and 27% of the Fortune 100 healthcare companies. The homepage now says more than half of the Fortune 50 healthcare companies, 8 of the top 10 pharma manufacturers and 350 million interactions automated. It names Amgen, UnitedHealthcare, Aetna, Novartis, Optum and Pfizer. These are the vendor's statements, and the testimonials come from Amgen SupportPlus and Accompany Health.

What does the security page say?

It states HIPAA rules are followed and BAAs are signed with customers and downstream vendors. It says the company "performs SOC 2 Type II auditing", with the report available through sales, and that it is CCPA compliant. It also says it "does not need to be compliant with EU GDPR". HITRUST and ISO 27001 appear there as Google Cloud's certifications.

How is it sold?

The site says "contact sales" in place of a price.

The verdict

Infinitus is well funded, with a $30M Series B and a $51.5M Series C on the record. Mandolin's homepage says it checks benefits on payer portals and by phone, and Clicks Health's FAQ says its agents call payers, so the calling is not unique to Infinitus.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Contact sales.

Source: vendor pricing page. Last checked November 2, 2026.

What deploys cleanly

Carries SOC 2 Type II, HIPAA per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.